every AI newsletter, junshi biology (SH 688180, closing price: 39.01 yuan) announced on the evening of September 27 that on September 27, 2023, the company repurchased about 390000 shares for the first time through centralized bidding through the trading system of Shanghai stock exchange, accounting for 0.0394 of the company's total share capital, with the highest repurchase transaction price of RMB 38.99 yuan per share, the lowest price is RMB 37.91/share, and the total amount of funds paid is about RMB 15.03 million.

from January to December 2022, Junshi biological's operating income composition is: pharmaceutical manufacturing accounted for 84.57.

the general manager of junshi biology is NING LI (Li ning), male, 62 years old, with a doctor's degree background.

as of press release, the market value of junshi biology is 38.5 billion yuan.

Dow (daoda1997) "individual stock trend" reminder:

1. Junshi Bio-U increased its northbound capital holdings by 429800 shares in the past 30 days, accounting for 0.09 of outstanding shares;

2. in the past 30 days, a total of 2 groups of institutions have conducted research on junshi biology-u, with a total of 124 institutions.

for more stock trend information, please search wechat public number "daoda number", reply to "query" and get free query permission!

every headline (nbdtoutiao)- the elderly anchor group brought fire "vitality 28", but the chairman said "difficulties every day"

(Reporter Jia YunKe)

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. Operate accordingly at your own risk.